Home/Rare Diseases/Focal Epilepsy

Neurological & Neuromuscular

Focal Epilepsy

Also called partial epilepsy, localization-related epilepsy, focal onset seizures, temporal lobe epilepsy

Focal epilepsy occurs when abnormal electrical activity repeatedly starts in a specific region of the brain. Unlike generalized epilepsy, which involves both brain hemispheres from the start, focal seizures begin in one area and may or may not spread.

View active trialsMatch me to a trial

About Focal Epilepsy

Focal epilepsy occurs when abnormal electrical activity repeatedly starts in a specific region of the brain. Unlike generalized epilepsy, which involves both brain hemispheres from the start, focal seizures begin in one area and may or may not spread. The seizures are classified as focal aware (consciousness preserved) or focal impaired awareness (consciousness affected), and can sometimes evolve into bilateral tonic-clonic seizures. The temporal lobe is the most common origin, but focal seizures can arise from any cortical region including the frontal, parietal, or occipital lobes. Each location produces characteristic symptoms. Diagnosis involves EEG monitoring to identify the seizure focus, MRI to look for structural causes, and sometimes advanced imaging like PET or SPECT scans. Treatment begins with anti-seizure medications, but roughly 30% of patients have drug-resistant focal epilepsy. For these patients, surgical evaluation is important, as resective surgery can be curative when a clear seizure focus is identified. Newer approaches including laser ablation, responsive neurostimulation (RNS), and vagus nerve stimulation offer additional options.

Common Symptoms

  • Auras or unusual sensations before seizures (déjà vu, rising stomach feeling, strange smells)
  • Staring spells with impaired awareness lasting 30 seconds to 2 minutes
  • Involuntary repetitive movements like lip smacking, hand rubbing, or picking at clothes
  • Confusion and disorientation after seizures
  • Memory difficulties, especially with temporal lobe involvement
  • Possible progression to bilateral tonic-clonic (grand mal) seizures

Who It Affects

Can develop at any age but most commonly begins in childhood or after age 60. Affects males and females roughly equally. Risk factors include head injury, stroke, brain tumors, brain infections, and genetic predisposition. Temporal lobe epilepsy is the most common subtype in adults.

Getting Involved in Clinical Trials

Drug-resistant focal epilepsy is a major area of clinical trial activity. Biohaven's opakalim (BHV-7000), a Kv7 ion channel activator, is in Phase 3 trials for focal epilepsy with topline results expected in 2026. Other active areas include cenobamate optimization studies, antisense oligonucleotides for genetic forms, novel neuromodulation devices, and gene therapy approaches. The Epilepsy Foundation maintains a trial matching service, and comprehensive epilepsy centers often have dedicated research programs enrolling patients with treatment-resistant seizures.

Trusted Sources

Active Clinical Trials for Focal Epilepsy

Finding trials for Focal Epilepsy...

Related Neurological & Neuromuscular Conditions

Neurological & Neuromuscular

Duchenne Muscular Dystrophy

Duchenne muscular dystrophy is an X-linked genetic disorder causing progressive muscle weakness and degeneration, beginn...

Neurological & Neuromuscular

Spinal Muscular Atrophy

Spinal muscular atrophy is an autosomal recessive genetic disorder affecting motor neurons in the spinal cord, causing p...

Neurological & Neuromuscular

Myasthenia Gravis

Myasthenia gravis is a chronic autoimmune neuromuscular disorder causing muscle weakness and rapid fatigue. Antibodies a...